Published in Clin Immunol Immunopathol on July 01, 1990
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Management of Kawasaki disease. Arch Dis Child (2013) 2.30
Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol (1998) 1.64
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr (2008) 1.63
Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet (2012) 1.30
Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J Clin Invest (1995) 1.19
Kawasaki disease. Yonsei Med J (2006) 1.16
Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol (1991) 1.12
Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study. PLoS One (2011) 1.08
Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology (1999) 1.04
Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr Rheumatol Online J (2011) 1.03
Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease. Clin Exp Immunol (1999) 0.96
Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease. Clin Exp Immunol (2004) 0.95
CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol (2000) 0.94
Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child (1992) 0.94
Cytokine induction by extracellular products of oral viridans group streptococci. Infect Immun (1993) 0.90
Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells. Clin Exp Immunol (1995) 0.90
Recent advances in the understanding and management of kawasaki disease. Curr Infect Dis Rep (2010) 0.89
Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin Exp Immunol (2001) 0.88
Recent Advances in Kawasaki Disease. Yonsei Med J (2016) 0.88
BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children. Eur J Pediatr (2009) 0.85
Inhibition of IL-12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD). Clin Exp Immunol (1998) 0.84
Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J Korean Med Sci (2005) 0.84
Regulation of the expression of Fc gamma receptor on circulating neutrophils and monocytes in Kawasaki disease. Clin Exp Immunol (1999) 0.84
Detection of Fcgamma receptors on human endothelial cells stimulated with cytokines tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma). Clin Exp Immunol (1998) 0.83
Infliximab treatment for pediatric refractory Kawasaki disease. Pediatr Cardiol (2011) 0.82
Plasma exchange for refractory Kawasaki disease. Eur J Pediatr (2004) 0.82
Genetic polymorphisms in the CD40 ligand gene and Kawasaki disease. J Clin Immunol (2008) 0.82
Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease. Clin Exp Immunol (1998) 0.81
Superantigen involvement and susceptibility factors in Kawasaki disease: profiles of TCR Vβ2+ T cells and HLA-DRB1, TNF-α and ITPKC genes among Filipino patients. Int J Mol Epidemiol Genet (2013) 0.81
Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease. J Korean Med Sci (2009) 0.81
Association between GRIN3A gene polymorphism in Kawasaki disease and coronary artery aneurysms in Taiwanese children. PLoS One (2013) 0.81
Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease. Medicine (Baltimore) (2016) 0.81
Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population. Pediatr Cardiol (2008) 0.80
Alteration of CD4CD25Foxp3 T cell level in Kawasaki disease. Korean J Pediatr (2011) 0.80
Coronary artery aneurysms occurrence risk analysis between Kawasaki disease and LRP1B gene in Taiwanese children. Biomedicine (Taipei) (2014) 0.80
The functions of endothelial progenitor cells were significantly improved after treatment with intravenous immunoglobulin and aspirin in children with Kawasaki disease. Pediatr Cardiol (2011) 0.79
Amino-terminal pro-B-type natriuretic peptide in refractory Kawasaki disease. Pediatr Cardiol (2009) 0.79
Genetic variants of glutamate receptor gene family in Taiwanese Kawasaki disease children with coronary artery aneurysms. Cell Biosci (2014) 0.78
Periostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarker. Pediatr Infect Dis J (2014) 0.78
Found in Translation: International initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki Disease. Arthritis Rheumatol (2016) 0.77
8p22-23-rs2254546 as a susceptibility locus for Kawasaki disease: a case-control study and a meta-analysis. Sci Rep (2014) 0.77
Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness. PLoS One (2016) 0.77
Regulation of oxidative stress in patients with Kawasaki disease. Inflammation (2012) 0.76
Pediatric Kawasaki Disease and Adult Human Immunodeficiency Virus Kawasaki-Like Syndrome Are Likely the Same Malady. Open Forum Infect Dis (2016) 0.76
GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease. J Exp Med (2016) 0.76
Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki disease. Curr Ther Res Clin Exp (2003) 0.75
miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease. Circ Res (2016) 0.75
Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities. Korean J Pediatr (2016) 0.75
Genetic variants in PLCB4/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in Taiwan. Sci Rep (2015) 0.75
A Case of Kawasaki Disease with Coronary Aneurysm Responding to the 4th IVIG Treatment. Case Rep Cardiol (2014) 0.75
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother (1997) 17.36
Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum (1992) 2.56
Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. Am Heart J (1973) 1.83
Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem (1991) 1.73
Voxel-based analysis of MRI reveals anterior cingulate gray-matter volume reduction in posttraumatic stress disorder due to terrorism. Proc Natl Acad Sci U S A (2003) 1.69
Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res (1996) 1.67
Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. Eur J Pediatr (1994) 1.64
Neurotoxicity of human eosinophils towards peripheral nerves. J Neurol Sci (1989) 1.52
Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis. Lupus (2005) 1.51
Pseudohyperkalaemia in Kawasaki disease. Eur J Pediatr (1992) 1.47
A case of infantile Dubin-Johnson syndrome with high CT attenuation in the liver. Pediatr Radiol (1997) 1.47
Clinical features of aortic arch anomaly with malalignment ventricular septal defect. Ann Thorac Surg (1989) 1.45
Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation (1996) 1.45
Radio-ulnar synostosis, short stature, microcephaly, scoliosis, and mental retardation. Am J Med Genet (1995) 1.40
Myocardial oxygen utilization after reversible global ischemia. J Thorac Cardiovasc Surg (1990) 1.40
Development of bronchial asthma after wheezing associated with respiratory infection in infancy. Acta Paediatr (1995) 1.40
Superantigens and Kawasaki disease. Immunol Today (1991) 1.39
Off-pump extraction of an embedded high posterior left ventricular bullet utilizing a new cardiac stabilization device. J Trauma (2001) 1.39
Alanylglutamine-enriched total parenteral nutrition improves protein metabolism more than branched chain amino acid-enriched total parenteral nutrition in protracted peritonitis. J Trauma (1997) 1.39
Amiodarone for atrial fibrillation during off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (2001) 1.39
Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol (1999) 1.35
Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol (1988) 1.35
Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.29
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis/encephalopathy. Neurology (1998) 1.27
Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob Agents Chemother (2001) 1.26
Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol (2005) 1.21
Washout measurement of radioisotope implanted by radioactive beams in the rabbit. Phys Med Biol (2003) 1.17
Perineural spread of adenoid cystic carcinoma in the oral and maxillofacial regions: evaluation with contrast-enhanced CT and MRI. Dentomaxillofac Radiol (2012) 1.16
Relationship between resting hypercapnia and physiologic parameters before and after lung volume reduction surgery in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.16
Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg (1996) 1.16
Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome. Circulation (1997) 1.15
Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its' intracellular expression in human megakaryocytes. Blood (1999) 1.15
Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells. Blood (1997) 1.15
Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys (2001) 1.13
Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol (1991) 1.12
Effect of aeration and unsaturated fatty acids on expression of the Saccharomyces cerevisiae alcohol acetyltransferase gene. Appl Environ Microbiol (1997) 1.12
Molecular cloning and characterization of a novel gene, CORS26, encoding a putative secretory protein and its possible involvement in skeletal development. J Biol Chem (2000) 1.11
Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg (1997) 1.08
Thiazolidine derivatives as potent inhibitors specific for prolyl endopeptidase. J Biochem (1988) 1.06
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res (2000) 1.05
Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl Infect Dis (2007) 1.05
Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol (1999) 1.03
Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status. J Clin Pathol (1998) 1.02
Effect of circulatory assist devices on stunned myocardium. Ann Thorac Surg (1990) 1.02
Expression of Fc epsilon R2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease. Clin Immunol Immunopathol (1990) 1.01
Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol Teratol (2002) 0.99
Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci Lett (2000) 0.98
Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone. J Neuroimmunol (1999) 0.98
Route of nutritional supply influences local, systemic, and remote organ responses to intraperitoneal bacterial challenge. Ann Surg (1996) 0.98
Progressive vascular lesions in Williams-Beuren syndrome. Pediatr Cardiol (1988) 0.98
The role of gender in heart transplantation. Ann Thorac Surg (1998) 0.98
NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin Immunol (2001) 0.98
Malignant mixed Müllerian tumor of the fallopian tube: a case report. Eur J Gynaecol Oncol (2012) 0.97
Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr (1992) 0.97
Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci Biotechnol Biochem (2000) 0.96
Dietary restriction impairs neutrophil exudation by reducing CD11b/CD18 expression and chemokine production. Arch Surg (2001) 0.96
Changes in hemodynamics and bradykinin concentration in coronary sinus blood in experimental coronary artery occlusion. Jpn Heart J (1977) 0.96
Production of gamma-aminobutyric acid by cheese starters during cheese ripening. J Dairy Sci (1998) 0.96
Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease. Clin Exp Immunol (1999) 0.96
Histopathologic and radiographic findings of the simple bone cyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 0.95
Evaluation of core decompression for early osteonecrosis of the femoral head. Arch Orthop Trauma Surg (2000) 0.95
Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer. Int J Radiat Oncol Biol Phys (1996) 0.95
Is transcatheter closure of patent ductus arteriosus using multiple coils feasible? Am J Cardiol (1995) 0.95
Synthesis and secretion of nerve growth factor by mouse astroglial cells in culture. Biochem Biophys Res Commun (1986) 0.94
The dsbA-dsbB disulfide bond formation system of Burkholderia cepacia is involved in the production of protease and alkaline phosphatase, motility, metal resistance, and multi-drug resistance. Microbiol Immunol (2000) 0.94
CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol (2000) 0.94
Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child (1992) 0.94
Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. Circulation (1996) 0.93
Comparison of outer membrane protein genes omp and pmp in the whole genome sequences of Chlamydia pneumoniae isolates from Japan and the United States. J Infect Dis (2000) 0.93
Is p-ANCA in ulcerative colitis directed against beta-glucuronidase? Lancet (1993) 0.93
Immunopathology of the skin lesion of Kawasaki disease. Prog Clin Biol Res (1987) 0.93
Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses. Clin Exp Immunol (2005) 0.93
Increase of cord blood cytokine-producing T cells in intrauterine infection. Pediatr Int (2001) 0.93
Systemically administered alpha-melanocyte-stimulating peptides inhibit NF-kappaB activation in experimental brain inflammation. Brain Res (1999) 0.93
Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr (1994) 0.92
Thyrotropin binding inhibitor immunoglobulin. Its pathogenetic importance in hypothyroidism. Am J Dis Child (1986) 0.92
Sodium/calcium exchange contributes to contraction and relaxation in failed human ventricular myocytes. Am J Physiol (1999) 0.91
Radiographic findings for solitary plasmacytoma of the bone in the anterior wall of the maxillary sinus: A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 0.91
Ratio of bacteria to polymorphonuclear neutrophils (PMNs) determines PMN fate. Shock (1999) 0.91
Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes. J Neurosci Res (1993) 0.91
A comparison of FcepsilonRI-mediated RANTES release from human platelets between allergic patients and healthy individuals. Int Arch Allergy Immunol (2001) 0.91
Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J Neurosci Res (1997) 0.90
Changes in components of kinin system and hemodynamics in acute myocardial infarction. Am Heart J (1978) 0.90
Heart disease screening in Japanese children. BMJ (1993) 0.90
Effect of lung volume reduction surgery on diaphragm length in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 0.90
Discrepancy between severity of lung impairment and seniority on the lung transplantation list. Transplant Proc (2004) 0.90
Infective endocarditis following orthotopic heart transplantation: 10 cases and a review of the literature. Transpl Infect Dis (2004) 0.89
Auditory cortical images of tones and noise bands. J Assoc Res Otolaryngol (2000) 0.89
Histological investigation of spinal cord lesions in the spinal hyperostotic mouse (twy/twy): morphological changes in anterior horn cells and immunoreactivity to neurotropic factors. J Neurol (1998) 0.89
Patients with renal hypouricemia are prone to develop acute renal failure--why? Clin Nephrol (1995) 0.89
Phase I/II study of high-dose rate interstitial radiotherapy for head and neck cancer. Strahlenther Onkol (1992) 0.89
Safety evaluation of hemagglutinating virus of Japan--artificial viral envelope liposomes in nonhuman primates. Hum Gene Ther (2001) 0.89
Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J Neurosci (1991) 0.88
Immunohistochemical studies on small intestinal mucosa in Kawasaki disease. Pediatr Res (1993) 0.88
The greater omentum is the primary site of neutrophil exudation in peritonitis. J Am Coll Surg (1996) 0.88
A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg (2001) 0.88
Preoperative total parenteral nutrition influences postoperative systemic cytokine responses after colorectal surgery. Nutrition (1997) 0.88
Effect of lung volume reduction surgery on diaphragm strength. Am J Respir Crit Care Med (1998) 0.88